Perspectives

Stay up-to-date with the current investment and macroeconomic issues at ClearBridge Investments. We provide analyses of the themes and trends which lie at the heart of your investment challenges.

Equity Insights
Transports Poised for Delayed Recovery

Transports Poised for Delayed Recovery

An extended contraction in U.S. manufacturing activity has left the transports industry mired in a freight recession, yet the emergence of reshoring and improving operating efficiencies leave high-quality operators attractively positioned for an economic recovery.

More...
Equity Insights Portfolio Insights Video
Introducing Global Growth

Introducing Global Growth

In this video, Portfolio Manager, Michael Testorf is joined by Head of APAC Business Development, Matt Bushby to introduce the Global Growth Strategy. Come along as they explore the Strategy and it's objectives.

More...
Anatomy of a Recession
AOR Update: Resilient Economy Gets More Credit

AOR Update: Resilient Economy Gets More Credit

Credit Spreads became the first indicator to turn green this month while Profit Margins improved to yellow, bringing the overall dashboard closer to green.

More...
Infrastructure Insights
Peak Rates a Good Sign for Infrastructure

Peak Rates a Good Sign for Infrastructure

Infrastructure has historically outperformed global equities as interest rates have peaked, something to keep in mind as inflation indicators slow and allow major central banks to end their hawkish positioning and move toward easing.

More...
Equity Insights Portfolio Insights Video
Introducing Global Value Improvers

Introducing Global Value Improvers

Join Portfolio Manager, Grace Su as she delves into the investment philosophy supporting the ClearBridge Global Value Improvers Strategy, and explores what the Strategy aims to achieve.

More...
Responsible Investing
ClearBridge Investments 2024 Stewardship Report

ClearBridge Investments 2024 Stewardship Report

ClearBridge Investments' annual stewardship report highlights how active ownership benefits from ESG integration and how company engagements and proxy voting create value and drive positive change.

More...
Infrastructure Insights
Infrastructure Multiples Point to a Potential Rerating

Infrastructure Multiples Point to a Potential Rerating

Despite headwinds to defensive stocks, infrastructure’s strong earnings growth, attractive valuations and predictable dividend stream make us quite constructive on the sector.

More...
The Challenge of Powering AI

The Challenge of Powering AI

The accelerating pace of power demands among AI aspirants is putting pressure on an already stretched electrical grid, which may cause a resetting of AI growth expectations. Higher power demand and pricing are creating powerful tailwinds for cyclical stocks supporting the AI buildout.

More...
Anatomy of a Recession Market Outlook
AOR Update: Wage Moderation Allows Fed Patience

AOR Update: Wage Moderation Allows Fed Patience

Jeff Schulze and Josh Jamner examine why slowing wage growth in the U.S. should offset fears that recent hot inflation prints could spur additional Fed tightening. They also explain how wages have achieved a “Goldilocks” zone supportive of a soft landing.

More...
Infrastructure Insights
Will Renewables Survive the Energy Transition?

Will Renewables Survive the Energy Transition?

While public funding for renewables may face increasing policy risk, regulators will continue to provide attractive returns for regulated utilities supporting the energy transition.

More...
Infrastructure Insights Video
Valuation of Infrastructure Assets Q1 2024

Valuation of Infrastructure Assets Q1 2024

In our latest Valuation update, Portfolio Manager, Simon Ong discusses the contributors to infrastructure returns in the first quarter of 2024, and weighs in on the factors impacting different infrastructure sectors across the globe.

More...
Equity Insights
International Companies Drive Diabesity Innovation

International Companies Drive Diabesity Innovation

Diabetes and obesity (“diabesity”) have rapidly become the largest opportunity in health care, with an estimated total long-term addressable market of $100 billion in the U.S. alone. Research & development outside the U.S. has provided actionable insights into the blockbuster market for diabesity treatments.

More...